Aspire Pharma - making a difference in the lives of patients through the development and supply of innovative products and medicines throughout the world
  • ABOUT US
  • PORTFOLIO
  • PARTNERSHIPS
  • RESEARCH
  • SOCIAL RESPONSIBILITY
  • NEWS
  • CAREERS
  • CONTACT
  • Search
  • Menu Menu
Press Releases

Reimagining Medicines Optimisation: A Call to Action for Addressing Health Inequalities

Petersfield, Hampshire, 30 October 2024 – Aspire Pharma Ltd in 2023 spearheaded an important initiative called Medicines Optimisation Centricity and initiated a White Paper published in May 2023 via Health Service Journal (HSJ), which urged…
October 30, 2024
https://aspirepharma.co.uk/wp-content/uploads/cropped-roundel512.png 512 512 admin https://aspirepharma.co.uk/wp-content/uploads/AspireLogoBlue700.png admin2024-10-30 13:38:202024-10-30 13:38:20Reimagining Medicines Optimisation: A Call to Action for Addressing Health Inequalities
Press Releases

Acquisition Strengthens Aspire Pharma’s Strategic Portfolio

Petersfield, Hampshire, 4 October 2024: Aspire Pharma Limited, a high growth UK-based specialty niche generics business, announces the further strengthening of its product portfolio through the acquisition of all assets from Canute Pharma Limited. The…
October 4, 2024
https://aspirepharma.co.uk/wp-content/uploads/cropped-roundel512.png 512 512 admin https://aspirepharma.co.uk/wp-content/uploads/AspireLogoBlue700.png admin2024-10-04 08:02:422024-10-04 08:02:42Acquisition Strengthens Aspire Pharma’s Strategic Portfolio
Press Releases

Medicines Optimisation Centricity – addressing Access & Choice to Medicine Inequalities and Inequities

Petersfield, Hampshire, 01 October 2024, Aspire Pharma Ltd has initiated and funded a new report on improving access and choice to medicines by bringing the patient into the centre of the decision-making process; which follows the publication…
October 1, 2024
https://aspirepharma.co.uk/wp-content/uploads/cropped-roundel512.png 512 512 admin https://aspirepharma.co.uk/wp-content/uploads/AspireLogoBlue700.png admin2024-10-01 13:22:542024-10-01 13:22:54Medicines Optimisation Centricity – addressing Access & Choice to Medicine Inequalities and Inequities
Press Releases

Aspire Advances its Growth Trajectory with Acquisition of Cenoté Pharma Ltd.

Petersfield, Hampshire, 11 March 2024, Aspire Pharma Limited, a rapidly growing specialty generics business, continues to supplement its strong organic growth with acquisitions and strategic partnerships with the successful completion of its…
March 11, 2024
https://aspirepharma.co.uk/wp-content/uploads/cropped-roundel512.png 512 512 admin https://aspirepharma.co.uk/wp-content/uploads/AspireLogoBlue700.png admin2024-03-11 11:34:092024-08-13 12:47:42Aspire Advances its Growth Trajectory with Acquisition of Cenoté Pharma Ltd.
Press Releases

Medicines Optimisation Centricity – Getting It Right

Petersfield, Hampshire, 01 November 2023, Aspire Pharma Ltd initiated and funded the set-up of a series of round table events to discuss Medicines Optimisation Centricity. These events, facilitated by Wilmington Healthcare, as a data intelligence…
November 1, 2023
https://aspirepharma.co.uk/wp-content/uploads/cropped-roundel512.png 512 512 admin https://aspirepharma.co.uk/wp-content/uploads/AspireLogoBlue700.png admin2023-11-01 14:24:222024-04-02 14:53:04Medicines Optimisation Centricity – Getting It Right
Press Releases

Aspire Pharma Continues LCCC’s Medical Centre Sponsorship

Leicestershire County Cricket Club (LCCC) is delighted to announce Aspire Pharma Ltd as the new sponsor of the club’s state-of-the-art medical centre at the Uptonsteel Ground, at Grace Road. Since 2016, the medical centre has been sponsored…
July 13, 2023
https://aspirepharma.co.uk/wp-content/uploads/Aspire-Pharma-Medical-Centre-scaled.jpg 1920 2560 admin https://aspirepharma.co.uk/wp-content/uploads/AspireLogoBlue700.png admin2023-07-13 13:40:482024-04-02 14:55:38Aspire Pharma Continues LCCC’s Medical Centre Sponsorship
Press Releases

Aspire Pharma acquires Morningside Pharmaceuticals and Morningside Healthcare

Aspire Pharma acquires Morningside Pharmaceuticals and Morningside Healthcare and its subsidiaries, including Morningside Healthcare (India) creating the UK’s premier Speciality Pharma company Petersfield, Hampshire, October 3rd 2022, Aspire…
October 3, 2022
https://aspirepharma.co.uk/wp-content/uploads/cropped-roundel512.png 512 512 admin https://aspirepharma.co.uk/wp-content/uploads/AspireLogoBlue700.png admin2022-10-03 09:00:202024-08-22 16:41:04Aspire Pharma acquires Morningside Pharmaceuticals and Morningside Healthcare
News

Aspire welcome its new Chief Executive Officer

It’s with great pleasure that Aspire officially welcome our new CEO, Richard Condon, to the company. Richard joins us from Bayer UK and as we embark on the next chapter, his leadership, knowledge, and experience, is a welcome addition to the…
April 5, 2022
https://aspirepharma.co.uk/wp-content/uploads/Richard-Condon-Headshot.jpg 500 700 admin https://aspirepharma.co.uk/wp-content/uploads/AspireLogoBlue700.png admin2022-04-05 09:00:212024-02-21 15:32:23Aspire welcome its new Chief Executive Officer
News

EPIMAX® sees an award-winning start to 2022

Aspire is delighted to announce the award-winning start to 2022 for its emollient range: EPIMAX®. EPIMAX® Oatmeal Cream was selected as a highly commended product in the Best Beauty on a Budget category at the ASOS Beauty Awards 2022. Beauty…
January 20, 2022
https://aspirepharma.co.uk/wp-content/uploads/epimax-1.jpg 265 373 admin https://aspirepharma.co.uk/wp-content/uploads/AspireLogoBlue700.png admin2022-01-20 09:00:072024-02-21 15:32:33EPIMAX® sees an award-winning start to 2022

social media

APL1010347H11_OCT2024

Follow us
  • About us
  • Portfolio
  • Partnerships
  • Research
  • Social Responsibility
  • News
  • Careers
  • Contact
  • Terms and Conditions
  • Terms and Conditions of Sale
  • Modern Slavery and Human Trafficking Policy
  • Cookie Policy
  • Data Protection
© Copyright 2024 Aspire Pharma Limited | Aspire Pharma Limited is registered in England, company number 06828501
Scroll to top